H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating
Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the best low priced biotech stocks to invest in. On April 13, H.C. Wainwright initiated coverage of Generate Biomedicines, Inc.

